MML Investors Services’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Buy
32,823
+8,050
+32% +$975K 0.01% 1197
2026
Q1
$4.05M Sell
24,773
-9,417
-28% -$1.45M 0.01% 924
2025
Q4
$5.95M Sell
34,190
-6,810
-17% -$1.24M 0.01% 777
2025
Q3
$5.9M Sell
41,000
-8,018
-16% -$982K 0.02% 753
2025
Q2
$4.93M Buy
49,018
+17,809
+57% +$1.36M 0.01% 794
2025
Q1
$2.38M Buy
31,209
+8,254
+36% +$631K 0.01% 1083
2024
Q4
$1.58M Buy
22,955
+754
+3% +$54.3K 0.01% 1248
2024
Q3
$1.62M Buy
22,201
+5,897
+36% +$435K 0.01% 1221
2024
Q2
$1.09M Buy
+16,304
New +$632K ﹤0.01% 1353

Other funds holding INSM

MML Investors Services's INSM Position: Q2 2026 in Review

MML Investors Services increased its Insmed (INSM) stake by 32% in Q2 2026, buying an estimated $975K and bringing the position to 32,823 shares worth $3.5M. The position accounts for 0.01% of the portfolio, ranked #1197.

MML Investors Services first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.95M in Q4 2025. 293 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • MML Investors Services held 32,823 shares of Insmed worth $3.5M as of Q2 2026.
  • MML Investors Services bought 8,050 Insmed shares in Q2 2026, an estimated $975K.
  • Insmed made up 0.01% of MML Investors Services's portfolio in Q2 2026, its #1197 holding.
  • MML Investors Services first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • MML Investors Services's Insmed position peaked at $5.95M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.